NasdaqGS - Delayed Quote USD
Editas Medicine, Inc. (EDIT)
2.1000
+0.1700
+(8.81%)
At close: June 10 at 4:00:01 PM EDT
2.1400
+0.04
+(1.90%)
Pre-Market: 4:08:02 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 279.6k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 1.72 per share. | Direct | 26,196 | Jun 3, 2025 |
| BURKLY LINDA Officer | Sale at price 1.72 per share. | Direct | 1,252 | Jun 3, 2025 |
| PARISON AMY Chief Financial Officer | Sale at price 1.72 per share. | Direct | 769 | Jun 3, 2025 |
| LUCERA ERICK J. Chief Financial Officer | Sale at price 1.71 per share. | Direct | 7,030 | Mar 4, 2025 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 1.71 per share. | Direct | 28,452 | Mar 4, 2025 |
| BURKLY LINDA Officer | Sale at price 1.71 per share. | Direct | 4,946 | Mar 4, 2025 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 2.08 per share. | Direct | 3,361 | Dec 3, 2024 |
| MEI BAISONG Officer | Sale at price 2.08 per share. | Direct | 1,124 | Dec 3, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 3.42 per share. | Direct | 5,325 | Sep 4, 2024 |
| MEI BAISONG Officer | Sale at price 3.42 per share. | Direct | 1,774 | Sep 4, 2024 |
| BURKLY LINDA Officer | Sale at price 5.42 per share. | Direct | 64,370 | Jul 25, 2024 |
| MEI BAISONG Officer | Sale at price 5.21 per share. | Direct | 34,456 | Jul 19, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 5.50 per share. | Direct | 66,997 | Jun 4, 2024 |
| MEI BAISONG Officer | Sale at price 5.50 per share. | Direct | 2,808 | Jun 4, 2024 |
| LUCERA ERICK J. Chief Financial Officer | Sale at price 5.61 per share. | Direct | 125,404 | May 20, 2024 |
| HOPFIELD JESSICA Director | Purchase at price 5.64 per share. | Direct | 253,868 | May 13, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Sale at price 9.42 per share. | Direct | 732,884 | Mar 5, 2024 |
| MEI BAISONG Officer | Sale at price 9.42 per share. | Direct | 191,425 | Mar 4, 2024 |
| LUCERA ERICK J. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| O NEILL GILMORE NEIL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| MEI BAISONG Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| BURKLY LINDA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| EATON BRUCE E Chairman of the Board | Sale at price 10.90 per share. | Direct | 1,122 | Dec 5, 2023 |
| EATON BRUCE E Chief Technology Officer | Sale at price 8.21 per share. | Direct | 5,706 | Nov 14, 2023 |
| EATON BRUCE E Chief Technology Officer | Sale at price 8.40 per share. | Direct | 1,168 | Nov 7, 2023 |
| EATON BRUCE E Chief Technology Officer | Sale at price 8.82 per share. | Direct | 908 | Sep 6, 2023 |
| EATON BRUCE E Chairman of the Board | Sale at price 8.59 per share. | Direct | 6,033 | Aug 11, 2023 |
| EATON BRUCE E Chairman of the Board | Sale at price 8.39 per share. | Direct | 1,183 | Aug 8, 2023 |
| BURKLY LINDA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 24, 2023 |
| MEI BAISONG Officer | Sale at price 8.80 per share. | Direct | 37,990 | Jul 19, 2023 |
Related Tickers
NTLA Intellia Therapeutics, Inc.
8.47
+2.29%
BEAM Beam Therapeutics Inc.
18.08
-0.50%
CRBU Caribou Biosciences, Inc.
1.2200
-3.94%
CRSP CRISPR Therapeutics AG
42.94
+2.02%
FATE Fate Therapeutics, Inc.
1.6700
+9.87%
VERV Verve Therapeutics, Inc.
6.39
+4.67%
PRME Prime Medicine, Inc.
1.5500
-7.19%
SGMO Sangamo Therapeutics, Inc.
0.5153
+1.04%
DNA Ginkgo Bioworks Holdings, Inc.
8.50
+8.42%
IOVA Iovance Biotherapeutics, Inc.
2.3800
+7.69%